CRDO Credo Technology Group Holding Ltd Insider Trading

CRDO COO Yat Tung Lam sells 50,000 shares for $11.3M via 18 transactions on 2026-07-15 under 10b5-1 plan; stock down -13.0% in 30 days.

Yat Tung Lam executed 18 separate sales totaling 50,000 shares for $11,272,535.01 on 2026-07-15 at prices ranging from $218.36 to $235.99, reducing his holdings by 12.5% to 350,000 shares. This sale was conducted under a pre-arranged 10b5-1 trading plan adopted on 2026-04-15, meaning it followed a predetermined schedule rather than a discretionary decision. The stock has declined -13.0% over the preceding 30 days and currently trades at $207.97, below the blended transaction average of $225.45. Yat Tung Lam's prior trades at CRDO (5 sells on 2025-12-11) showed negative 90-day returns ranging from -22.4% to -26.9%, while his cross-ticker track record shows an average 90-day return of -20.5% following 20 prior sells.

COO Yat Tung Lam sold 56.0K shares ($12.6M) on 2026-07-15 under 10b5-1 plan; stock down 32.6% from 52-week high.

Yat Tung Lam, COO of Credo Technology Group Holding Ltd, executed 18 separate sales totaling 55,998 shares for $12,624,399.76 on 2026-07-15. This transaction is part of a pre-arranged 10b5-1 trading plan adopted on 2026-04-15, meaning the sales were scheduled and not discretionary. The insider retained 2,584,610 shares post-transaction, representing a 2.1% reduction from prior holdings. While the blended sale price averaged $225.44, the current stock price of $207.97 is 32.6% below the 52-week high of $308.67 and down 13.0% over 30 days. His prior sales at CRDO consistently resulted in negative 90-day returns (ranging from -22.4% to -26.9%), though the scheduled nature of this plan removes any inference about timing discretion. The company's fundamentals show strong revenue of $407.0M and net income of $157.1M, with 205.7% annual revenue growth, though the P/E of 51.10 reflects high valuation expectations that the recent stock decline may challenge.

CTO Chi Fung Cheng sells 27,500 shares for $6,605,778.70 via 14-tranche execution on 2026-07-14 under 10b5-1 plan.

Chi Fung Cheng, Chief Technology Officer of Credo Technology Group (CRDO), executed 14 separate sales totaling 27,500 shares for $6,605,778.70 on 2026-07-14 under a pre-arranged 10b5-1 trading plan adopted on 2025-09-05, reducing his holdings by 0.5% from 5,882,370 to 5,854,870 shares. The multi-tranche structure spanning prices from $236.34 to $250.28 (blended average $240.21) reflects scheduled execution rather than discretionary market timing. Stock price has declined 32.6% from its 52-week high of $308.67 to the current $207.97, a -13.0% move over the prior 30 days, despite fundamentals showing 205.7% annual revenue growth and $157.1M net income in the latest quarter. The filing documents routine insider portfolio management under a contractual trading schedule, with no material change to the CTO's voting control or operational role.

CFO Daniel Fleming sold 7,580 shares ($1.9M) via 10 scheduled transactions at prices $240.61–$249.61; -23.3% from 52-week high.

Daniel W. Fleming, Chief Financial Officer of Credo Technology Group Holding Ltd, executed 10 separate sales totaling 7,580 shares for $1,863,771.82 on 2026-07-08 under a pre-arranged 10b5-1 trading plan adopted 2026-01-12. The sales occurred at prices ranging from $240.61 to $249.61, with a blended average of $245.88, while the current stock price stands at $236.88 (down 23.3% from the 52-week high of $308.67). This was a modest reduction of his holdings, declining from 512,288 shares to 504,708 shares (a 1.5% reduction). His prior five sales at CRDO on 2026-06-11 showed positive 30-day returns of 2.2% to 6.3%, though the scheduled nature of these transactions via the pre-arranged plan removes discretionary timing as a factor in this evaluation. CRDO has demonstrated strong fundamentals with latest quarterly revenue of $407,012,000.00 and net income of $157,142,000.00, paired with 205.7% annual revenue growth and a P/E ratio of 58.20, though the stock has declined 5.6% over the past 30 days.

CTO Chi Fung Cheng sells 31,290 shares (31.3K shares) for $7,664,770.75 ($7.7M) via scheduled 10b5-1 plan at CRDO

Chi Fung Cheng, Chief Technology Officer at Credo Technology Group, executed 18 separate sales totaling 31,290 shares for $7,664,770.75 on 2026-07-07 and 2026-07-08, representing an -18.2% reduction in his prior holdings of 171,648 shares. This transaction is part of a pre-arranged 10b5-1 trading plan adopted on 2025-09-05, meaning the sales were scheduled and not discretionary timing decisions. The company is currently valued at $49.5B with strong fundamentals (latest quarterly revenue $407.0M, net income $157.1M, annual revenue growth +205.7%), and the current stock price of $265.65 reflects a 13.4% gain over 30 days and a 122.1% gain over 90 days. His same-ticker trade history at CRDO includes five prior sales on 2026-06-23, indicating a pattern of systematic liquidations under the pre-arranged plan. Given the scheduled nature of these sales, the focus is on the execution frequency and volumes rather than market timing.

CTO Chi Fung Cheng sells 27,500 shares for $7.4M under pre-arranged 10b5-1 plan; holds 5.91M post-sale

Chi Fung Cheng executed 21 separate sales totaling 27,500 shares for $7,420,535.04 on 2026-06-30 under a pre-arranged 10b5-1 trading plan adopted on 2025-09-05, meaning the sales were scheduled rather than discretionary. The blended average sale price of $269.84 stands above the current price of $241.91, reflecting the -21.6% drawdown from the 52-week high of $308.67 that has occurred since the plan was adopted. The sale represents -0.5% of pre-transaction holdings, leaving Cheng with 5.91M shares; prior to this filing, Cheng executed 5 sales at CRDO on 2026-06-23 whose outcomes are not yet measurable. The scheduled nature of this transaction limits inference of discretionary conviction, though the company's strong fundamentals—annual revenue growth of +126.3%, net income of $157.1M on revenue of $407.0M, and market cap of $44.6B—provide context for the executive's continued substantial stake of 5.91M shares post-sale.

CTO Chi Fung Cheng executes 14 separate sales totaling 27,500 shares for $7,450,978.83 under pre-arranged 10b5-1 plan

Chi Fung Cheng, Chief Technology Officer at Credo Technology Group Holding Ltd, executed 14 separate sales totaling 27,500 shares for $7,450,978.83 on 2026-06-23, representing a 0.5% reduction from his 5.96M share position. This transaction was executed under a pre-arranged 10b5-1 trading plan adopted on 2025-09-05, meaning the sales were scheduled and not discretionary. At the time of filing, CRDO stock was trading at $268.03, approximately 13.2% below its 52-week high of $308.67 but up 20.9% over the prior 30 days. The company reported strong recent fundamentals with revenue of $407.0M, net income of $157.1M, and annual revenue growth of 126.3%, though the stock carries a high valuation multiple (P/E 145.67). As a scheduled disposition under a 10b5-1 plan, this transaction reflects pre-existing commitments rather than a discretionary trading decision by the executive.

CTO Chi Fung Cheng sells 27,500 shares for $6,783,985.43 under pre-arranged 10b5-1 plan; holds 5,964,870 post-transaction

Chi Fung Cheng executed 17 separate sales totaling 27,500 shares for $6,783,985.43 on 2026-06-16 at prices ranging from $239.60 to $257.61, with a blended average price of $246.69. This transaction is part of a pre-arranged 10b5-1 trading plan adopted on 2025-09-05, meaning the sales were scheduled in advance and not discretionary decisions made in response to current market conditions. Post-transaction holdings of 5,964,870 shares represent a -0.5% reduction against prior holdings, a modest fraction of his total position. CRDO's stock has risen 60.9% over 30 days and 162.9% over 90 days, trading at $271.83 current price, near its 52-week high of $271.51. The company posted strong recent fundamentals with annual revenue growth of +126.3% and net income of $157,142,000.00 in the latest quarter, though the P/E of 147.73 reflects a substantially elevated valuation multiple. The scheduled nature of these sales under the 10b5-1 plan removes any inference of discretionary timing or conviction-based positioning from the transaction itself.

CLO James Laufman sells 5,000 CRDO shares at $264.48; stock at $259.41; 30d return +50.7%, 90d return +149.3%

James Laufman, Chief Legal Officer and Secretary, sold 5,000 shares at $264.48 on 2026-06-11 for $1,322,425.00, reducing holdings from 186,230 to 181,230 shares (-2.7%). The transaction occurred after a sharp 30-day rally of +50.7% and a 90-day rally of +149.3%, placing the stock near its 52-week high of $270.21 (current price $259.41 is -4.0% from peak). His cross-ticker track record shows 7 prior sells with a 40.00% well-timed rate and average 90d return of +39.7%, indicating a history of sales that tend to precede declines. At CRDO specifically, his prior 5 trades show mixed timing: two recent 2026 sales (2026-06-04 and 2026-04-15) lack measurable outcomes, but his 2025-12-24 sale preceded a 90-day decline of -33.1%, consistent with successful exit timing. This sale follows a third consecutive transaction at CRDO within six weeks and comes as the stock has appreciated substantially in the near term, suggesting a disciplined approach to liquidity management at elevated valuations.

CFO Daniel W. Fleming sells 40,000 shares (7.4% of holdings) for $9,979,281.93 via 10b5-1 plan; stock up 50.7% in 30 days.

Daniel W. Fleming, CFO of Credo Technology Group, executed 11 separate sales totaling 40,000 shares for $9,979,281.93 on 2026-06-11 at a blended average price of $249.48. The transaction was conducted under a pre-arranged 10b5-1 trading plan adopted on 2026-01-12, meaning the sales were scheduled rather than discretionary. This sale reduced his holdings from 541,873 to 501,873 shares, a reduction of 7.4%. The company's fundamentals show strong growth (annual revenue growth of +126.3%) with a current market cap of $47,848,158,935.40, though the P/E of 140.98 reflects a significantly elevated valuation. The stock has demonstrated substantial recent momentum (+50.7% in the past 30 days and +149.3% in the past 90 days), trading at $259.41 as of the current price, only 4.0% below its 52-week high of $270.21. Fleming's prior sales at this ticker show mixed outcomes: two recent April 2026 sales posted positive 30-day returns (+20.2% and +21.0%), while three January sales resulted in negative 30-day and 90-day returns (ranging from -13.0% to -20.5%).